Regulations of Bacillus Coagulans

Weizmannia coagulans BC99

Identifiers

FormulaC3H6O3·CAS50-21-5·EC200-018-0·HS2918.11

Hazards

CorrosiveIrritant

How does the regulatory treatment of bacillus coagulans differ by market or product category?

The available evidence shows only a US regulatory flag for bacillus coagulans: an EPA TSCA exemption from Chemical Data Reporting Rule (CDR) reporting under 40 CFR 711. No market-specific or product-category distinctions are documented, so differences between dietary supplements, foods, or pharmaceuticals cannot be established from this evidence. This means a compliance assessment cannot rely on category-specific regulatory treatment beyond the TSCA exemption. Business decisions should treat the regulatory landscape as undifferentiated until further jurisdiction- or category-specific data is obtained.

Which United States federal regulations apply to Bacillus coagulans?

8 regulations

EPA TSCA Regulatory Flag

Propanoic acid, 2-hydroxy- is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Propanoic acid, 2-hydroxy- are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

FIFRA Requirements

Lactic acid (2-hydroxypropanoic acid) is exempted from the requirement of a tolerance when used as a plant growth regulator in or on all raw agricultural commodities.

FDA Direct Food Additives

Regulatory records

EntryRegulationTypeStatusSource
178.101021 CFR 178.1010Food AdditiveauthorizedView
184.106121 CFR 184.1061Food AdditiveauthorizedView
133.12321 CFR 133.123Labeling StandardsauthorizedView
133.12421 CFR 133.124Labeling StandardsauthorizedView
133.12921 CFR 133.129Labeling StandardsauthorizedView
133.16921 CFR 133.169Labeling StandardsauthorizedView
133.17321 CFR 133.173Labeling StandardsauthorizedView
133.17821 CFR 133.178Labeling StandardsauthorizedView
133.17921 CFR 133.179Labeling StandardsauthorizedView

FDA 21 CFR Indirect Food Additives

Regulatory records

EntryRegulationTypeStatusSource
172.81421 CFR 172.814Food AdditiveauthorizedView

FDA GRAS Notices

Corrosive to skin; [Quick CPC] A skin and respiratory tract irritant; Corrosive to eyes; [ICSC] Causes burns to skin and eyes; Vapors cause eye and mucous membrane irritation and can cause coughing and difficulty breathing; [CHRIS] Safe when used as a flavoring agent in food; [JECFA] Corrosive to rabbit skin, mildly irritating to guinea pig skin, and not irritating to pig skin; Not sensitizing in a study of guinea pigs; A 13-week oral study of rats produced a NOAEL of 500 mg/kg/day (highest tested dose); Studies on reproductive and developmental toxicity not considered necessary because lactic acid is a product of human intermediary metabolism; [EPA ChAMP] A skin and strong eye irritant; [Aldrich MSDS]

FDA Food Contact Notifications

Food contact notifications

NotificationManufacturer / supplierIntended useLimitationsEffectiveStatus
1995
VValley Chemical Solutions
As an antimicrobial agent in process water, brine, or ice in the processing of meat and poultry.Components of the FCS mixture will not exceed: 1000 parts per million (ppm) PLA, 2480 ppm HP, 5.7 ppm HEDP, and 1.64 ppm DPA in process water or ice that contacts meat or poultry carcasses, parts, trim, and organs. 268 ppm PLA, 665 ppm HP, 1.53 ppm HEDP, and 0.44 ppm DPA in process water, ice, or brine that contacts processed and pre-formed meat and poultry.30 Oct 2019active
2242
EEvonik Active Oxygens, LLC
As an antimicrobial agent used in process water, ice, or brine used in the production, processing, and preparation of poultry, meat, processed and pre-formed meat and poultry, fruits, vegetables, fish, and seafood.The components of the FCS will not exceed: 2000 ppm PCA, 2480 ppm HP, and 136 ppm HEDP in process water, ice, or brine applied as a wash, spray, dip, rinse, chiller water, low-temperature (less than 40°F) immersion bath, or scald water for whole or cut poultry, including carcasses, parts, trim, and organs. 495 ppm PCA, 1180 ppm HP, and 29 ppm HEDP in process water, ice, or brine for washing, rinsing, or cooling processed and pre-formed poultry. 2000 ppm PCA, 2480 ppm HP, and 121.5 ppm HEDP in process water, ice, or brine applied as a wash, spray, dip, rinse, chiller water, low-temperature (less than 40°F) immersion bath, or scald water for whole or cut meat, including carcasses, parts, trim, and organs. 495 ppm PCA, 1180 ppm HP, and 33.5 ppm HEDP in process water, ice, or brine for washing, rinsing, or cooling processed and pre-formed meat. 600 ppm PCA, 1112 ppm HP, and 34 ppm HEDP in process water or ice used for washing, rinsing, chilling, or processing fruits and vegetables in food processing facilities. 230 ppm PCA, 280 ppm HP, and 15 ppm HEDP in process water, ice, or brine used during commercial preparation of fish and seafood in food processing facilities.28 Sept 2022active

FDA Technical Effects

Regulatory records

RegulationStatus
FDA Technical Effect: ANTIMICROBIAL AGENTauthorized
FDA Technical Effect: CURING OR PICKLING AGENTauthorized
FDA Technical Effect: FLAVOR ENHANCERauthorized
FDA Technical Effect: FLAVORING AGENT OR ADJUVANTauthorized
FDA Technical Effect: PH CONTROL AGENTauthorized
FDA Technical Effect: SOLVENT OR VEHICLEauthorized

DEA Listed Chemicals

SRP: Expired or waste pharmaceuticals shall carefully take into consideration applicable DEA, EPA, and FDA regulations. It is not appropriate to dispose by flushing the pharmaceutical down the toilet or discarding to trash. If possible return the pharmaceutical to the manufacturer for proper disposal being careful to properly label and securely package the material. Alternatively, the waste pharmaceutical shall be labeled, securely packaged and transported by a state licensed medical waste contractor to dispose by burial in a licensed hazardous or toxic waste landfill or incinerator.

What EU regulatory requirements apply to Bacillus coagulans?

3 regulations

REACH Registered Substance

Status: Active Update: 04-01-2023 https://echa.europa.eu/registration-dossier/-/registered-dossier/5165

EFSA Legal Basis

Regulation (EC) No 178/2002 (amended)

Status Regulation (EC)

2004/129/EC

What regulations apply to Bacillus coagulans in Canada?

1 regulation

DSL / NDSL

Published
04 May 1994
Effective
04 May 1994

Regulatory records

EntryRegulationTypeStatus
50-21-5SOR/94-311DSLauthorized

Conditions

This substance is on the Domestic Substances List (DSL). This substance was added to the DSL as an “Existing Substance” given that it meets the criteria set out in CEPA for substances that were in commerce in Canada between 1984 and 1986.

Record details

SOR/94-311

professional use only
No

What regulations apply to Bacillus coagulans in Australia?

1 regulation

The Australian Inventory of Industrial Chemicals

Chemical: Propanoic acid, 2-hydroxy-

What regulations apply to Bacillus coagulans in New Zealand?

1 regulation

New Zealand EPA Inventory of Chemical Status

Lactic acid: Does not have an individual approval but may be used under an appropriate group standard

Which conditions, limits, and use contexts most affect a compliance assessment for bacillus coagulans?

The only documented condition is the US EPA TSCA exemption from CDR reporting, which applies to the substance itself and does not specify use conditions, concentration limits, or product-category constraints. No other limits or use contexts are provided in the evidence. For a compliance assessment, this means the substance is not subject to CDR reporting under the stated rule, but other federal or state requirements may still apply. Formulators should not infer broader safety or usage limits from this exemption, as it is a reporting flag, not a use authorization.

What should be in place before a product containing bacillus coagulans is assessed for launch?

Before launch assessment, the only confirmed regulatory documentation is the EPA TSCA exemption from CDR reporting, which should be verified for applicability to the specific product form and use. No other pre-launch documentation—such as food additive petitions, GRAS determinations, or drug approvals—is evidenced. This means the compliance file is incomplete for most product categories, and additional regulatory research is necessary to identify applicable requirements. The TSCA exemption alone does not satisfy potential FDA or other agency obligations.

Where does the available regulatory position stop short of supporting a decision on bacillus coagulans?

The regulatory position stops at a single US TSCA reporting exemption, which does not address safety, efficacy, or market authorization. There is no evidence of FDA drug or food additive status, no international regulatory data, and no product-category-specific guidance. Consequently, the available information cannot support a launch decision for any product category. Decision-makers should treat the regulatory status as largely unknown beyond the TSCA flag and commission further research to fill the gap before proceeding.